Jubilant Pharmova Ltd is an integrated global pharmaceuticals company having three business segments i.e. pharmaceuticals, contract research and development services and proprietary novel drugs.
Financial Results:
Jubilant Pharmova Ltd reported Revenues for Q4FY24 of ₹1,759.00 Crores up from ₹1,678.00 Crore year on year, a rise of 4.83%.
Total Expenses for Q4FY24 of ₹1,661.00 Crores down from ₹1,786.00 Crores year on year, a fall of 7.0%.
Consolidated Net Profit of -₹62.00 Crores from -₹100.00 Crores in the same quarter of the previous year.
The Earnings per Share is -₹3.68, from -₹6.15 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.